Cell-based Flu Vaccine Market

Cell-based Flu Vaccine Market contains market size and forecasts of Cell-based Flu Vaccine in global, including the following market information:

Global Cell-based Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Cell-based Flu Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)

Global top five Cell-based Flu Vaccine companies in 2021 (%)

The global Cell-based Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trivalent Influenza Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cell-based Flu Vaccine include GlaxoSmithKline, Sanofi, Pfizer, MedImmune, LLC, Intravacc, CSL Limited, E. Merck KG, Novartis and Danaher Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cell-based Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell-based Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Cell-based Flu Vaccine Market Segment Percentages, by Type, 2021 (%)

• Trivalent Influenza Vaccine
• Quadrivalent Influenza Vaccine

Global Cell-based Flu Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Cell-based Flu Vaccine Market Segment Percentages, by Application, 2021 (%)

• Aldults
• Children

Global Cell-based Flu Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Cell-based Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cell-based Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cell-based Flu Vaccine revenues share in global market, 2021 (%)
• Key companies Cell-based Flu Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)
• Key companies Cell-based Flu Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Sanofi
• Pfizer
• MedImmune, LLC
• Intravacc
• CSL Limited
• E. Merck KG
• Novartis
• Danaher Corporation
• SINOVAC